65 results
424B3
SCNI
Scinai Immunotherapeutics Ltd
16 May 24
Prospectus supplement
1:49pm
in English to the extent such materials are required to be translated into English pursuant to any regulations of the Commission.
The Depositary will keep … not to be unreasonably withheld, which shall contain (a) such information (including, without limitation, solicitation materials) as is contained
D
SCNI
Scinai Immunotherapeutics Ltd
12 Jan 24
$1.69 mm in equity / options / securities to be acquired, sold $1.69 mm, 4 investors
7:32am
instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials under … this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
424B3
SCNI
Scinai Immunotherapeutics Ltd
2 Jan 24
Prospectus supplement
9:58am
such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein “SEC Reports
424B3
7lf tds34f7n0mrjk9hh
2 Jan 24
Prospectus supplement
9:57am
6-K
EX-10.1
nqv 0mf7ht8t8b4yk
2 Jan 24
Report of Foreign Private Issuer
9:26am
D
vdv6of qo9q6ggv4tx3v
3 Oct 23
$1.33 mm in equity / options / securities to be acquired, sold $1.33 mm, 1 investor
12:38pm
6-K
EX-1.1
2lb 63gejvcjka6s7x4
19 Sep 23
Report of Foreign Private Issuer
3:06pm
424B3
nhikyo c4cq
7 Sep 23
Prospectus supplement
5:27pm
6-K
EX-99.1
sfp70 gj95cu9pr52
12 Jul 23
Report of Foreign Private Issuer
12:00am
10-K
49f f4hb1225npu
17 Apr 23
Annual report
4:06pm
10-K
EX-14.1
ygfy4 bbu5
17 Apr 23
Annual report
4:06pm
10-K
EX-4.1
wvdg wcjtf5fh9d
17 Apr 23
Annual report
4:06pm
6-K
EX-1.1
tawrr
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
424B4
6c3gw1juh2f891
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-1.1
5to gjpsrcj9doi
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
3r1t8
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
424B3
txyyad c2jcfc2eb6nzv
16 Nov 22
Prospectus supplement
12:01pm
6-K
EX-99.1
txd5nrg9j8x
10 Nov 22
Current Report
5:28pm